- GlobeNewswire•2 hours agoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit – BIIB
NEW YORK, Oct. 21, 2016-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Biogen Inc. between July 23, 2014 ...
Given the current scenario of increased political, media and public pressure on drug pricing, it makes sense to zero in on companies that are in the biosimilars business.
Biogen Inc. (BIIB), a well-known name in the multiple sclerosis (MS) market, will be reporting third-quarter 2016 earnings on Oct 26, before market open.
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||290.88 x 300|
|Ask||290.98 x 100|
|Day's Range||289.78 - 300.32|
|52wk Range||223.02 - 333.65|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||16.98|
|Avg Vol (3m)||1,658,026|
|Dividend & Yield||N/A (N/A)|